Our Science

Oncology

Neuroendocrine tumors, kidney, liver, pancreatic, medullary thyroid cancer, prostate and breast cancer

Ipsen’s commitment to oncology is demonstrated by its growing portfolio of therapies aimed at improving the lives of people living with cancer.

Neuroscience

Neurodegenerative, rare neuroinflammatory and movement disorders

With over 25 years of research, development and commercial experience in neuroscience, we are fully committed to improving health outcomes for patients suffering from debilitating neurological disorders.

Rare disease

Bone disorders, growth disorders, rare cancers and rare neurogenetic disorders

Working with the rare disease community, we strive to better understand the challenges faced by those living with rare diseases and their families, and then use our expertise to help address them.

R&D

At Ipsen, our research decisions are guided by patient outcomes.

Emphasizing a culture of open innovation, we focus our R&D efforts on accelerating prioritized internal projects while actively sourcing external assets.